US EditionPublished • loading... • Updated
Royal Bank Of Canada $RY Stake Lessened by Generali Asset Management SPA SGR
Perigon Wealth Management raised its AbbVie stake by 3.6% to 111,108 shares valued at $25.7 million amid positive quarterly earnings and a 3.0% dividend yield.
- In the third quarter, Perigon Wealth Management LLC lifted its stake in AbbVie Inc. by 3.6% after purchasing 3,905 shares, owning 111,108 shares valued at $25,726,000.
- Reporting strong earnings, AbbVie reported $1.86 earnings per share, topping the $1.77 consensus, and posted $15.78 billion in revenue versus $15.58 billion estimates.
- Among other filings, Vanguard Group Inc. raised its AbbVie stake by 1.9% to 177,298,707 shares while Norges Bank bought a new position worth $4,288,200,000.
- Hedge funds and other institutional investors own 70.23% of AbbVie, and sell-side analysts remain active with recent upgrades and price-target moves.
- AbbVie set a payment date of Tuesday, February 17th and shareholders of record on Friday, January 16th will be paid $1.73 per share, with an annualized dividend of $6.92 and a 3.0% yield.
Insights by Ground AI
5 Articles
5 Articles
Perigon Wealth Management LLC Purchases 3,905 Shares of AbbVie Inc. $ABBV
Perigon Wealth Management LLC lifted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 111,108 shares of the company’s stock after purchasing an additional 3,905 shares during the quarter. Perigon Wealth Management LLC’s holdings in AbbVie were worth $25,726,000 as of its most recent SEC filing. Several other large investors…
Coverage Details
Total News Sources5
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
